ATE230725T1 - Azetidinonderivate zur behandlung von hcmv entzündungen - Google Patents
Azetidinonderivate zur behandlung von hcmv entzündungenInfo
- Publication number
- ATE230725T1 ATE230725T1 AT98947255T AT98947255T ATE230725T1 AT E230725 T1 ATE230725 T1 AT E230725T1 AT 98947255 T AT98947255 T AT 98947255T AT 98947255 T AT98947255 T AT 98947255T AT E230725 T1 ATE230725 T1 AT E230725T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- het
- aryl
- phenyl
- lower alkyl
- Prior art date
Links
- 241000701024 Human betaherpesvirus 5 Species 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 title 1
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical class O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 125000000041 C6-C10 aryl group Chemical group 0.000 abstract 1
- 206010011831 Cytomegalovirus infection Diseases 0.000 abstract 1
- 108010016626 Dipeptides Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical class 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- -1 methoxy, ethoxy Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6155097P | 1997-10-07 | 1997-10-07 | |
| PCT/CA1998/000952 WO1999018071A1 (en) | 1997-10-07 | 1998-10-06 | Azetidinone derivatives for the treatment of hcmv infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE230725T1 true ATE230725T1 (de) | 2003-01-15 |
Family
ID=22036487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98947255T ATE230725T1 (de) | 1997-10-07 | 1998-10-06 | Azetidinonderivate zur behandlung von hcmv entzündungen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6239125B1 (de) |
| EP (1) | EP1021404B1 (de) |
| JP (1) | JP2001519328A (de) |
| AT (1) | ATE230725T1 (de) |
| AU (1) | AU9425998A (de) |
| CA (1) | CA2301548C (de) |
| DE (1) | DE69810651T2 (de) |
| DK (1) | DK1021404T3 (de) |
| ES (1) | ES2187063T3 (de) |
| PT (1) | PT1021404E (de) |
| WO (1) | WO1999018071A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005274927B2 (en) | 2004-07-15 | 2011-11-03 | Albany Molecular Research, Inc. | Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| KR100599876B1 (ko) * | 2004-08-31 | 2006-07-13 | 한국화학연구원 | 2-아릴메틸아제티딘 카바페넴 유도체 및 그의 제조방법 |
| US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| US8802696B2 (en) * | 2009-05-12 | 2014-08-12 | Albany Molecular Research, Inc. | 7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoqu inoli and use thereof |
| WO2010132487A1 (en) | 2009-05-12 | 2010-11-18 | Bristol-Myers Squibb Company | CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF |
| CN102458123A (zh) * | 2009-05-12 | 2012-05-16 | 阿尔巴尼分子研究公司 | 芳基、杂芳基和杂环取代的四氢异喹啉及其用途 |
| AU2019339777B2 (en) | 2018-09-12 | 2022-09-01 | Novartis Ag | Antiviral pyridopyrazinedione compounds |
| US11667613B2 (en) | 2019-09-26 | 2023-06-06 | Novartis Ag | Antiviral pyrazolopyridinone compounds |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5229381A (en) | 1983-12-01 | 1993-07-20 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| US4680391A (en) | 1983-12-01 | 1987-07-14 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| IL89835A0 (en) * | 1988-04-11 | 1989-12-15 | Merck & Co Inc | Substituted azetidinones,their preparation and pharmaceutical compositions containing them |
| EP0377549B1 (de) | 1989-01-03 | 1998-12-09 | Marcos Y. Kleinerman | Fernmessung physikalischer Variablen mit faseroptischen Systemen |
| US5104862A (en) | 1991-03-20 | 1992-04-14 | Merck & Co., Inc. | Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
| US5100880A (en) | 1991-03-20 | 1992-03-31 | Merck & Co., Inc. | Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
| GB2266527A (en) * | 1992-03-17 | 1993-11-03 | Merck & Co Inc | Substituted azetidinones useful in the treatment of leukemia |
| GB9314350D0 (en) * | 1993-07-12 | 1993-08-25 | Zeneca Ltd | Armide derivatives |
| NZ282488A (en) * | 1994-03-23 | 1999-09-29 | Tokyo Tanabe Co | Therapeutic or prophylactic medicament for viral disease containing antileukoprotease (serine protease inhibitor) |
| JP2001508395A (ja) * | 1996-01-11 | 2001-06-26 | スミスクライン・ビーチャム・コーポレイション | 新規シクロアルキル置換イミダゾール |
| AU710876B2 (en) * | 1996-02-21 | 1999-09-30 | Darwin Discovery Limited | Quinolones and their therapeutic use |
| JPH09255547A (ja) * | 1996-03-22 | 1997-09-30 | Kao Corp | 皮膚外用剤 |
-
1998
- 1998-10-06 PT PT98947255T patent/PT1021404E/pt unknown
- 1998-10-06 WO PCT/CA1998/000952 patent/WO1999018071A1/en not_active Ceased
- 1998-10-06 DE DE69810651T patent/DE69810651T2/de not_active Expired - Lifetime
- 1998-10-06 DK DK98947255T patent/DK1021404T3/da active
- 1998-10-06 AU AU94259/98A patent/AU9425998A/en not_active Abandoned
- 1998-10-06 EP EP98947255A patent/EP1021404B1/de not_active Expired - Lifetime
- 1998-10-06 ES ES98947255T patent/ES2187063T3/es not_active Expired - Lifetime
- 1998-10-06 JP JP2000514883A patent/JP2001519328A/ja not_active Ceased
- 1998-10-06 CA CA002301548A patent/CA2301548C/en not_active Expired - Fee Related
- 1998-10-06 AT AT98947255T patent/ATE230725T1/de active
- 1998-10-06 US US09/167,142 patent/US6239125B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK1021404T3 (da) | 2003-03-24 |
| DE69810651D1 (de) | 2003-02-13 |
| CA2301548C (en) | 2005-05-17 |
| EP1021404A1 (de) | 2000-07-26 |
| EP1021404B1 (de) | 2003-01-08 |
| US6239125B1 (en) | 2001-05-29 |
| JP2001519328A (ja) | 2001-10-23 |
| ES2187063T3 (es) | 2003-05-16 |
| CA2301548A1 (en) | 1999-04-15 |
| PT1021404E (pt) | 2003-04-30 |
| WO1999018071A1 (en) | 1999-04-15 |
| AU9425998A (en) | 1999-04-27 |
| DE69810651T2 (de) | 2003-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20030969A1 (es) | Compuestos heterociclicos, activos inhibidores de beta-lactamasas | |
| DE69315079D1 (de) | Beta-aminoalkyl und beta-n-peptidylaminoalkylborsäure | |
| DE69330949D1 (de) | Gaba und l-glutaminsaüre analoga zur behandlung der epilepsie | |
| SE8201854L (sv) | N-substituerade amino-aminosyror | |
| ATE315397T1 (de) | Neurotrophin antagoniste zur behandlung von der epilepsie, alzheimer'schen krankheit und schmerzen | |
| ZA934997B (en) | Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives | |
| DE3853577D1 (de) | Benzyliden-Malononitril-Derivate zur Hemmung von proliferativen Prozessen in Säugetierzellen. | |
| CA2224438A1 (en) | Vinyl-pyrrolidinone cephalosporins with basic substituents | |
| ATE224872T1 (de) | Azetidinonderivate zur behandlung von hcmv entzündungen | |
| FI913614A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten N-sulfonyyli-indoliinijohdannaisten valmistamiseksi | |
| DE69810651D1 (de) | Azetidinonderivate zur behandlung von hcmv entzündungen | |
| DE69624582D1 (de) | Ester und amide als pla2-inhibitoren | |
| ATE231124T1 (de) | Azetidinonderivate zur behandlung von hcmv entzündungen | |
| DE69132707D1 (de) | N-Acyldipeptide, und pharmazeutische Präparate davon | |
| NO20024811L (no) | FremgangsmÕte ved syntese av N-[(S)-1-karboksybutyl]-(S)- alaninestere og anvendelse i syntesen av perindopril | |
| ES2067635T3 (es) | Derivados heterociclicos de beta-aminoacidos acilaminodiolicos. | |
| DE69408888D1 (de) | Neue reaktive Thiophosphat-Derivate von Thia(dia)zol-Essigsäure und Verfahren zur Herstellung derselben | |
| NO975499L (no) | Form III krystallinsk (R-(R*,R*)-2(4-fluorfenyl)-<beta>-<delta>-dihydroksy-(1-metyl-etyl)-3-fenyl-4-(fenylamino)karbonyl)-1H-pyrrol-1-heptansyre-hemi-kalsiumsalt | |
| DE59903722D1 (de) | Verfahren zur Herstellung von 3-Amino-2-oxo-pyrrolidinen, Zwischenprodukte und deren Verwendung | |
| NZ331180A (en) | Specific immunophilin ligands with indole structure as antiasthmatics and immunosuppressants | |
| MX9708422A (es) | Esteres de carbapenemas. | |
| NO177853C (no) | Analogifremgangsmåter for fremstilling av N-substituerte azaheterocykliske karboksylsyrer | |
| DE50000905D1 (de) | Verfahren zur Herstellung von N-Acyl-aminosäureestern und N-Acyl-aminoacetalen | |
| HUP0203921A2 (hu) | Diazepin-karboxamid-származékok, eljárás a vegyületek előállítására, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1021404 Country of ref document: EP |